Table 2.
Characteristics of patients undergoing TAVI by post-procedure MR improvement.
| Improved (N = 31) | Not-improved (N = 34) | p-value | |
|---|---|---|---|
| Age (years) | 78.7 ± 10.2 | 77.6 ± 10.1 | 0.648 |
| Gender | 0.180 | ||
| Male | 17 (54.8%) | 13 (38.2%) | |
| Female | 14 (45.2%) | 21 (61.8%) | |
| Body mass index | 28.5 ± 7.2 | 31.1 ± 5.6 | 0.109 |
| Normal | 8 (25.8%) | 7 (20.6%) | 0.229 |
| Overweight | 13 (41.9%) | 9 (26.5%) | |
| Obese | 10 (32.3%) | 18 (52.9%) | |
| Blood pressure (mmHg) | |||
| Systolic | 136.5 ± 25.2 | 135.8 ± 25.9 | 0.908 |
| Diastolic | 66.3 ± 11.7 | 67.3 ± 11.8 | 0.751 |
| Heart rate | 74.8 ± 12.3 | 73.0 ± 14.7 | 0.609 |
| EuroScore for operative risk | 26.3 ± 19.3 | 19.9 ± 12.5 | 0.126 |
| Low risk (⩽20) | 17 (48.6%) | 18 (51.4%) | 0.356 |
| High risk (>20) | 14 (50.0%) | 14 (50.0%) | |
| MR cause | 0.968 | ||
| Functional | 18 (48.6%) | 19 (51.4%) | |
| Organic | 13 (48.1%) | 14 (51.9%) | |
| Medical history | |||
| Hypertension | 19 (61.3%) | 27 (84.4%) | 0.039 |
| Diabetes | 18 (58.1%) | 25 (78.1%) | 0.087 |
| Chornic obstructive pulmonary disease | 7 (22.6%) | 10 (31.2%) | 0.438 |
| Coronary artery disease | 14 (45.2%) | 20 (60.6%) | 0.216 |
| Myocardial infarction | 4 (12.9%) | 10 (31.2%) | 0.080 |
| CABG | 4 (12.9%) | 7 (20.6%) | 0.409 |
| Stroke | 3 (9.7%) | 5 (15.6%) | 0.708 |
| Carotid disease | 8 (25.8%) | 9 (27.3%) | 0.894 |
| Atrial fibrillation | 8 (26.7%) | 4 (13.3%) | 0.197 |
| Peripheral vascular disease | 17 (58.6%) | 19 (63.3%) | 0.711 |
| Percutaneous coronary intervention | 11 (35.5%) | 10 (30.3%) | 0.659 |
| Hemoglobin (g/dl) | 12.1 ± 1.3 | 12.2 ± 1.7 | 0.815 |
| Anemia | 13 (44.8%) | 11 (37.9%) | 0.594 |
| Platelets count (1000/μl) | 266.0 ± 65.5 | 252.5 ± 76.5 | 0.480 |
| Serum creatinine (mg/dl) | 1.09 ± 0.78 | 1.05 ± 0.52 | 0.882 |
| Hospital stay (days) | 20.9 ± 18.6 | 14.9 ± 9.0 | 0.284 |